Screenshot 2022 12 22

Found: A protective probiotic for ALS

Montreal, December 20, 2022 — A probiotic bacterium called Lacticaseibacillus rhamnosus HA-114 prevents neurodegeneration in the C. elegans worm, an animal model used to study amyotrophic lateral sclerosis (ALS). That’s the finding of a new study at Canada’s CHUM Research Centre…

Read More

Blue Light Therapy and PTSD Episode 1114 Fall 2022

Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age | Pediatrics | JAMA Network Open | JAMA Network

December 14, 2022 Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age Farid L. Khan, MPH1; Jennifer L. Nguyen, ScD1; Tanya G. Singh, MPH2; et alLaura A. Puzniak, PhD1; Timothy L. Wiemken, PhD1; Joshua P. Schrecker, PharmD3; Michael S. Taitel, PhD2; Joann…

Read More